2M0A Stock Overview
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Fiore Cannabis Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.044 |
| 52 Week Low | CA$0.0005 |
| Beta | 1.71 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -98.53% |
| 3 Year Change | n/a |
| 5 Year Change | -99.98% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2M0A | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.3% | -0.2% |
| 1Y | -98.5% | -16.3% | 2.4% |
Return vs Industry: 2M0A underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.
Return vs Market: 2M0A underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 2M0A volatility | |
|---|---|
| 2M0A Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 2M0A's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 2M0A's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | n/a | fiorecannabis.com |
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd.
Fiore Cannabis Ltd. Fundamentals Summary
| 2M0A fundamental statistics | |
|---|---|
| Market cap | €1.37m |
| Earnings (TTM) | -€6.88m |
| Revenue (TTM) | €1.66m |
0.8x
P/S Ratio-0.2x
P/E RatioIs 2M0A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2M0A income statement (TTM) | |
|---|---|
| Revenue | CA$2.40m |
| Cost of Revenue | CA$2.72m |
| Gross Profit | -CA$327.00k |
| Other Expenses | CA$9.59m |
| Earnings | -CA$9.92m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.05 |
| Gross Margin | -13.65% |
| Net Profit Margin | -414.15% |
| Debt/Equity Ratio | -1,396.5% |
How did 2M0A perform over the long term?
See historical performance and comparison